Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults

Background. The 4 serotypes of dengue virus, DENV-1-4, are the leading cause of arboviral disease globally. The ideal dengue vaccine would provide protection against all serotypes after a single dose. Methods. Two randomized, placebo-controlled trials were performed with 168 flavivirus-naive adults to demonstrate the safety and immunogenicity of a live attenuated celý popis

Uloženo v:

Podrobná bibliografie

Publikováno v
The Journal of infectious diseases Ročník 212; číslo 5; s. 702 - 710
Hlavní autoři
Kirkpatrick, Beth D., Durbin, Anna P., Pierce, Kristen K., Carmolli, Marya P., Tibery, Cecilia M., Grier, Palmtama L., Hynes, Noreen, Diehl, Sean A., Elwood, Dan, Jarvis, Adrienne P., Sabundayo, Beulah P., Lyon, Caroline E., Larsson, Catherine J., Jo, Matthew, Lovchik, Janece M., Luke, Catherine J., Walsh, Mary, Fraser, Ellen A., Subbarao, Kanta, Whitehead, Steven S.
Typ dokumentu
Journal Article
Jazyk
English
Vydáno
United States Oxford University Press 01. 09. 2015
Edice
Editor's choice
Témata
Bibliografie
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
B. D. K. and A. P. D. are co–first authors.
Presented in part: 62nd Annual Meeting of the American Society of Tropical Medicine and Hygiene, Washington, D.C., November 2013.
ISSN
0022-1899
1537-6613
1537-6613
DOI
10.1093/infdis/jiv082